Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson's Disease Foundation Launches Online Course for Occupational Therapy Practitioners

The Parkinson's Disease Foundation® (PDF®) is pleased to launch a new online course, Occupational Therapy: Across the Parkinson's Disease Continuum, to prepare occupational therapy practitioners who are caring for the growing population of people living with Parkinson's disease.

The number of people with Parkinson's disease is expected to double by 2030. While no treatment can prevent or reverse the disease, research suggests that occupational therapy can help people with Parkinson's disease to experience a better quality of life.

"We know that for people with Parkinson's, losing the ability to work, exercise or perform daily tasks, such as dressing and bathing, can be devastating. Occupational therapy can help people to maintain these important activities and their independence for as long as possible," said Linda Tickle-Degnen, Ph.D., O.T.R./L., F.A.O.T.A., faculty for the course and Professor of Occupational Therapy at Tufts University's Graduate School of Arts and Sciences.

Despite these benefits, there are currently no formal training programs available to support the practitioners who are fighting this complex disease on the front lines. Occupational Therapy: Across the Parkinson's Disease Continuum is a four-module course that offers practitioners the latest in best practice care from experts in the fields of occupational therapy and Parkinson's disease. Through collaboration with the American Occupational Therapy Association (AOTA), continuing education units (CEUs) are available to those who view the course online.

"It is critical, both for people living with Parkinson's and their care partners, to build a health care team that is knowledgeable in the complexities of this chronic progressive disease, and we increasingly understand that the occupational therapist is a critical member of that team," noted Jay Phillips and Marilyn Phillips, P.T., faculty members for the course and members of the PDF People with Parkinson's Advisory Council. "As the first of its kind, PDF's course empowers occupational therapists working on the front lines by putting the latest evidence-based findings in their hands."

"PDF recognizes the important work that occupational therapy practitioners are doing each and every day to improve the lives of people with Parkinson's disease," added Robin Anthony Elliott, President of PDF. "We are pleased to launch this course, as part of PDF's investment in helping to prepare leaders in research, health care and the patient community, and to ensure that professionals have the tools they need to learn about the disease and treat it most effectively."

About Parkinson's Disease
Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the US. Although promising research is being conducted, there is currently no cure for Parkinson's disease.

About Occupational Therapy: Across the Parkinson's Disease Continuum
Occupational Therapy: Across the Parkinson's Disease Continuum is an online course designed by and for occupational therapy practitioners to ensure best practice care for people with Parkinson's disease. Course faculty include leaders in the fields of occupational therapy and Parkinson's disease including: Sue Berger, Ph.D., O.T.R./L., B.C.G., F.A.O.T.A., of Boston University College of Health and Rehabilitation Sciences: Sargent College; Erin R. Foster, O.T.D., M.S.C.I., O.T.R./L., of the Program in Occupational Therapy at Washington University School of Medicine in St. Louis; Sotirios Parashos, M.D., Ph.D., of Struthers Parkinson's Center and the University of Minnesota; Jay Phillips, of the PDF People with Parkinson's Advisory Council; Marilyn Phillips, P.T., of the PDF People with Parkinson's Advisory Council; Linda Tickle-Degnen, Ph.D., O.T.R./L., F.A.O.T.A., of Tufts University's Graduate School of Arts and Sciences; and Ingrid Sturkenboom, Ph.D., O.T., M.A., of Radboud University Medical Center, Nijmegen, The Netherlands. Through collaboration with the American Occupational Therapy Association, continuing education units are available to qualifying occupational therapy practitioners who view the course. The AOTA will offer a maximum of 7 contact hours/ .7 CEUs and 8.75 NBCOT PDUs for participants upon completion of all four modules. This course has been made possible with support from Susan Granat Weil. To learn more, visit support.pdf.org/occupationaltherapy.

Tuesday, March 1, 2016
New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Delegates From The Parkinson’s Community Converge On Capitol Hill To Advocate For Critical Research Funding
Monday, March 5, 2018

—2018 Parkinson’s Policy Forum Co-Sponsored by the Parkinson’s Foundation and the Michael J. Fox Foundation for Parkinson’s Research—

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.